CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,512,357
+$1,455,149 QoQ
Shares Held
339,275
+3.3% QoQ
Ownership
0.470%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,344,284,536 across 299 Biotechnology names. FDMT ranks #147 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in FDMT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,512,357 | 339,275 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,057,208 | 328,379 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,650,432 | 353,391 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,657,897 | 305,857 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,094,602 | 295,041 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $913,382 | 282,781 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,718,952 | 308,609 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,657,206 | 338,317 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,091,786 | 337,865 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,628,251 | 302,205 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,442,605 | 268,638 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,290,806 | 258,508 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,808,011 | 266,077 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,749,242 | 218,106 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,817,349 | 216,900 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,695,973 | 210,942 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,229,184 | 176,101 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,866,918 | 189,611 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,043,520 | 184,299 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,914,803 | 145,154 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,522,337 | 63,220 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,514,608 | 57,967 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||